Sign in
Not yet taking people in United StatesNo phase

New questionnaire to measure symptoms in people with cardiac dysautonomia

Tests a new symptom questionnaire in adults with cardiac dysautonomia.

Key facts

Who runs it
Kansas City Heart Rhythm Research Foundation
Where
Overland Park, United StatesSee the 3 sites
Trial code
Registry title
Development and Validation of the Kansas City Cardiac Dysautonomia Questionnaire (KCDysQ)
Status
Not yet recruiting
People taking part
100 people, planned
Started
Jan 2026
Planned end
Aug 2026
Type of study
Interventional, 2 groups
Treatments tested
  • Kansas City Cardiac Dysautonomia Questionnaire (KCDysQ)
Record updated
28 August 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with POTS, IST (a fast heart rate at rest without a clear cause) or vasovagal syncope (fainting). They will fill in a new questionnaire about how the condition affects daily life.

Age
18 Years and older
Sex
All
Disease stage
Diagnosis of POTS, IST or vasovagal syncope. People can be newly diagnosed or untreated, or already diagnosed and treated, including after sinus node modification.

Main reasons for not taking part

  • Severe heart failure (NYHA Class III or IV)
  • Severe COPD (GOLD 3 or 4, Group C or D)
  • Current cancer not in remission
  • Autoimmune disease needing long-term steroids or immune-changing drugs, such as rheumatoid arthritis, lupus, sarcoidosis or psoriasis
  • Kidney failure needing haemodialysis, cirrhosis of the liver, or an organ or bone marrow transplant needing immune-suppressing drugs

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Patients with a Diagnosis of POTS, IST, or vasovagal syncope

Who cannot take part

  • Patients with comorbid chronic conditions causing significant impairments in quality of life, defined as:
  • NYHA Class III or IV Heart Failure
  • Any patients with current malignancy not in remission
  • Any patient with history of Autoimmune disease requiring chronic steroid therapy or immunomodulatory agents: Rheumatoid Arthritis, Lupus, Sarcoidosis, Psoriasis All patients with ESRD requiring hemodialysis All patients with cirrhosis of any origin Any patients with solid organ or bone marrow transplant requiring immunosuppressive therapy
  • COPD GOLD 3 or 4, Group C or D

Where in United States

  • Kansas City Heart Rhythm InstituteOverland Park, United StatesContact: Donita AtkinsNot yet recruiting
  • Midwest Heart and Vascular SpecialistsOverland Park, United StatesContact: Donita AtkinsNot yet recruiting
  • Overland Park Regional Medical CenterOverland Park, United StatesContact: Donita AtkinsNot yet recruiting

About the trial

What the trial wants to find out

Main aim will be to compare in patients with cardiac dysautonomia, newly developed disease specific questionnaire to established generalized SF-36 and EQ-5d questionnaires, as there are no disease specific questionnaires for comparison. These novel and established questionnaires will then be compared among groups who have relatively stable disease or stable symptoms with patients who will be expected to have a change in symptoms and QoL.

The 2 groups in the trial

  • Newly diagnosed/untreated/incompletely treated for Cardiac Dysautonomia PatientsOther group

    Newly diagnosed/untreated/incompletely treated for Cardiac Dysautonomia (Postural Orthostatic Tachycardia Syndrome (POTS), Inappropriate Sinus Tachycardia (IST), and Vasovagal syncope (VVS)) Patients

    Treatment: Kansas City Cardiac Dysautonomia Questionnaire (KCDysQ)

  • Previously diagnosed/treated/undergone sinus node modification for Cardiac Dysautonomia PatientsOther group

    Previously diagnosed/treated/previously undergone sinus node modification for Cardiac Dysautonomia Patients (Postural Orthostatic Tachycardia Syndrome (POTS), Inappropriate Sinus Tachycardia (IST), and Vasovagal syncope (VVS)) Patients

    Treatment: Kansas City Cardiac Dysautonomia Questionnaire (KCDysQ)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Development and Validation of the Kansas City Cardiac Dysautonomia Questionnaire (KCDysQ) in Patients With Postural Orthostatic Tachycardia Syndrome, Inappropriate Sinus Tachycardia, and Other Disorders of Cardiac Dysautonomia
Plain-language title
New questionnaire to measure symptoms in people with cardiac dysautonomiaGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
28 August 2025